Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, …
biotechnology
-
-
Eli Lilly’s obesity pill was approved by the Food and Drug Administration on Wednesday, setting it …
-
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how …
-
Alex Zhavoronkov, CEO of Insilico Medicine, can’t stop complimenting Eli Lilly. “Lilly is better in AI …
-
Arulmozhi, P. et al. Extraction methods and computational approaches for evaluation of antimicrobial compounds from Capparis …
-
Want to stay on top of the science and politics driving biotech today? Sign up to …
-
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, …
-
At yesterday’s STAT Breakthrough Summit East, Medicare chief Chris Klomp offered a tempered view of TrumpRx, …
-
The escalating war in the Middle East so far has not appreciably disrupted global pharmaceutical supply …
-
You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence …
